1 型糖尿病的共刺激基因和通路-猫眼课题宝

1 型糖尿病的共刺激基因和通路

批准号：

7777314

负责人：

Linda S. Wicker

金额：

$32.55万

依托单位：

BRIGHAM AND WOMEN'S HOSPITAL

依托单位国家：

美国

项目类别：

财政年份：

资助国家：

美国

项目状态：

未结题

起止时间：

至

来源：

https://reporter.nih.gov/project-details/7777314

关键词：

3&apos Untranslated Regions Address Affect Alleles Animal Model Autoimmune Diseases Autoimmunity Blocking Antibodies Blood Cells CD4 Positive T Lymphocytes CD58 gene CD8B1 gene CSF1 gene CTLA4 gene Candidate Disease Gene Caucasians Caucasoid Race Cells Chromosomes, Human, Pair 3 Collaborations Collection Complement Congenic Strain Control Locus Development Disease Event Experimental Autoimmune Encephalomyelitis Family Family member Gene Expression Genes Genetic Genetic Recombination Genetic Variation Genotype Goals Graves&apos Disease Histocompatibility Antigens Class II Human IL2RA gene Immune In Vitro Inbred NOD Mice Individual Insulin-Dependent Diabetes Mellitus Knockout Mice Knowledge Ligands MHC Class II Genes Membrane Messenger RNA Modeling Molecular Multiple Sclerosis Mus PTPN22 gene Pathway interactions Patients Phosphoric Monoester Hydrolases Physiological Predisposition Prevention Protein Isoforms Proteins RNA Splicing Regulation Research Personnel Role Sampling Signal Transduction Staging T memory cell T-Cell Activation T-Lymphocyte Testing Variant autoimmune thyroid disease base case control comparative congenic healthy volunteer in vivo mouse model novel programs promoter resistance allele

项目摘要

项目成果

Linda S. Wicker的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

The overall goal of this application is to understand the genetic basis of type 1 diabetes (T1D) and other autoimmune diseases. This knowledge can then be applied to their treatment, cure, and eventual prevention. In the case of T1D, the availability of several animal models, especially the NOD mouse, has complemented the efforts to localize human genes and has shown that some of the same genes, e.g. those encoding MHC class II molecules and the costimulatory molecule CTLA-4, are associated with TID in both species in a primary, causative way. There is also growing evidence that autoimmune diseases including T1D, autoimmune thyroid disease and multiple sclerosis (MS) are likely to be influenced by some of the same genes. For example, variation in the CTLA-4 molecule affects the course of both Graves' disease and T1D in humans and T1D and EAE in the mouse. The first aim is to determine if additional shared genes control the development of T1D in humans and mice. Idd10 and Idd18.2 contribute to the genetic control of T1D in NOD mice and may overlap with MS. The primary candidates in Idd10 are the polymorphic genes encoding B7H4 and CD101 and for Idd18.2, CD2 and IgSFS. Using novel congenic strains of mice and comparative sequence and expression studies, the candidacy of these genes will be tested. The influence of candidate genes defined by the Idd10 and Idd18.2 regions will be assessed in T1D using a staged genotyping strategy in a family collection (748 families) and a new case-control collection (> 4,000 T1D cases and 4,000 controls). The second aim focuses on the consequences of genetic variation in the human CTLA-4 gene. Peripheral blood cells from genotyped individuals, normal and patients with T1D, will be used to study the regulation of the soluble isoform of CTLA-4. In the third aim, the function of CD101, a costimulatory molecule whose expression is influenced by the CTLA4 genotype, will be studied in human peripheral blood cells and in a knockout mouse model.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文